A detailed history of First Capital Advisors Group, Llc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, First Capital Advisors Group, Llc. holds 46 shares of JAZZ stock, worth $5,485. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46
Holding current value
$5,485
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023

BUY
$122.5 - $147.16 $5,635 - $6,769
46 New
46 $5,000
Q2 2018

Jul 30, 2018

SELL
$146.33 - $183.18 $3,658 - $4,579
-25 Closed
0 $0
Q1 2018

Apr 11, 2018

BUY
$135.59 - $157.16 $3,389 - $3,929
25 New
25 $4,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.47B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track First Capital Advisors Group, Llc. Portfolio

Follow First Capital Advisors Group, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Capital Advisors Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on First Capital Advisors Group, Llc. with notifications on news.